Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

ABSTRACT: Objectives: Ceftolozane/tazobactam is a cephalosporin/β-lactamase inhibitor combination with activity against Gram-negative bacilli. Here we report the use of ceftolozane/tazobactam in Canada using a national registry. Methods: The CLEAR registry uses a REDCapTM online survey to capture d...

Full description

Bibliographic Details
Main Authors: George G. Zhanel, Rita Dhami, Melanie Baxter, Justin Kosar, Carlos Cervera, Neal Irfan, Rosemary Zvonar, Sergio Borgia, Jean-Francois Tessier, Gordon Dow, Robert Ariano, Maxime Dube, Michel Savoie, Matteo Bassetti, Andrew Walkty, James A. Karlowsky
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Ceftolozane/tazobactam
CLEAR
Efficacy
Adverse effect
Pneumonia
Bacteraemia
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716521000953

Internet

http://www.sciencedirect.com/science/article/pii/S2213716521000953

Similar Items